<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Hashimoto disease":1,
"autoimmunity":1,
"biopsy":2,
"cytology":2,
"fine-needle aspiration cytology":2,
"thyroid neoplasms":4,
"Fine needle aspiration":1,
"Suspicious malignancy":1,
"Thyroid lesions":1,
"benign mixed tumor":1,
"myoepithelioma":1,
"thyroid nodule":7,
"clear cell carcinoma":1,
"delayed metastases":1,
"hyalinizing":1,
"lymph node metastases":1,
"salivary gland":1,
"EMG":1,
"Lymphoma":1,
"Muscle Disease":1,
"Neurochemistry, Muscle":1,
"Neuromuscular":1,
"bilateral axillo-breast approach":2,
"oncoplastic thyroid surgery":1,
"robotic thyroidectomy":2,
"CCL2/CCR2":1,
"TR4":1,
"metastasis":3,
"prostate cancer":2,
"convoluted nuclei":1,
"liquid-based cytology":1,
"papillary carcinoma":4,
"thyroid":7,
"Compensation":1,
"Glutaminolysis":1,
"M2-type pyruvate kinase":1,
"miR-200a":1,
"β-Catenin/c-Myc":1,
"TiNi-based endograft":1,
"larynx cancer":1,
"larynx reconstruction":1,
"prefabricated flap":1,
"sparing surgery":1,
"Adjuvant therapy":1,
"Differentiated thyroid carcinoma":1,
"Radioiodine ablation":1,
"Total thyroidectomy":2,
"Urinary iodine":1,
"Aortic stiffness":1,
"Cardiovascular risk":1,
"Differentiated thyroid cancer":3,
"Subclinical hyperthyroidism":1,
"cancer":1,
"glottis":1,
"larynx":1,
"mouse":1,
"supraglottis":1,
"central lymph nodes":1,
"papillary thyroid carcinoma":5,
"radioactive iodine":2,
"thyroglobulin":2,
"Connective tissue disorder":1,
"Major cervical vessel rupture":1,
"Osteogenesis imperfecta":1,
"Spontaneous rupture of ICA":1,
"Weakness of the vessel wall":1,
"outcome":2,
"robot":1,
"Computed tomography":1,
"incidental lesion":1,
"thyroid malignancy":2,
"ultrasound":4,
"BRAF":2,
"haem oxygenase-1":1,
"immunohistochemistry":6,
"thyroid cancer":15,
"comforters and carers":1,
"molecular radiotherapy":1,
"neuroblastoma":1,
"radiation exposure":1,
"Chernobyl nuclear accident":1,
"latency":1,
"morphology":1,
"pathology":1,
"radiation":2,
"IMP3":1,
"nucleophosmin":1,
"NIS":1,
"microRNA-339-5p":1,
"radioiodide uptake":1,
"MEN2":1,
"RET oncogene":1,
"genetics":1,
"medullary thyroid carcinoma":2,
"multiple endocrine neoplasias":1,
"Lymph node":2,
"Neck dissection":1,
"Papillary thyroid cancer":5,
"Recurrence":1,
"Anteroposterior/transverse diameter ratio":1,
"Thyroid nodules":1,
"Virtual touch tissue quantification value":1,
"Carcinomas":1,
"Ectopic thyroid":1,
"Surgical management":1,
"Thyroglossal duct cyst":1,
"Neck mass":1,
"Pediatric thyroid":1,
"Pediatric thyroidectomy":1,
"Bone loss":1,
"Thyroid hormone":1,
"Benchmark":1,
"chemotherapy":1,
"evidence based":1,
"utilisation rate":1,
"Incidental findings":1,
"imaging":1,
"incidentaloma":1,
"Autoimmune thyroid diseases":1,
"CXCL10":1,
"Chemokines":1,
"Cytokines":1,
"Graves' disease":1,
"Hashimoto's thyroiditis":3,
"BRAF V600E mutation":1,
"RNA in situ hybridization":1,
"Nuclear sites":1,
"Prevailing wind directions":1,
"Radioactive discharge simulations":1,
"Residential proximity":1,
"Surrogate-exposure modelling":1,
"Acoustic Radiation Force Impulse":1,
"Virtual Touch Tissue Quantification":1,
"Chernobyl":1,
"chromosome rearrangement":1,
"signature":1,
"Interleukin-17":1,
"Polymorphism":1,
"Receptors":1,
"Single nucleotide":1,
"Thyroid neoplasm":2,
"Autophagamir":1,
"MTC":1,
"autophagy":3,
"medullary":1,
"miR-9-3p":1,
"oncophagy":1,
"Carcinoma":3,
"Knock-out mice":1,
"Ovary":1,
"cl2/dro1/ccdc80":1,
"E-cadherin":1,
"ERβ1":1,
"Id1":1,
"Invasion":2,
"Migration":1,
"ALK":1,
"gene rearrangement":1,
"Dog":1,
"IFN-γ":1,
"Isoflurane":1,
"NK cytotoxic activity":1,
"Carcinogenicity":1,
"In utero exposure":1,
"Mammary fibroadenomas":1,
"Myopathy":1,
"Neuropathy":1,
"Thyroid follicular cell tumors":1,
"Biologie moléculaire":1,
"Cancer de la thyroïde":2,
"Molecular biology":1,
"Targeted therapy":1,
"Thérapies ciblées":1,
"cytologic diagnosis":1,
"immunocytochemistry":1,
"insular carcinoma":1,
"microfollicular pattern":1,
"upfront diagnosis":1,
"Graves’ disease":1,
"Maladie de Basedow":1,
"Nodule non-palpable":1,
"Non-palpable nodule":1,
"Ultrasonography":2,
"Échographie":2,
"Doppler":1,
"solid variant of papillary thyroid carcinoma":1,
"Carcinoma showing thymus-like elements":1,
"EGFR gene amplification":1,
"GLUT-1":1,
"Gene mutation":1,
"Immunophenotype":1,
"Ultrastructure":1,
"IGFBP5":1,
"Proliferation":1,
"miR-204-5p":1,
"A20":1,
"BAP1":1,
"CYLD":1,
"UCHL1":1,
"USP22":1,
"USP7":1,
"ataxin 3":1,
"deubiquitinases":1,
"expected survival":1,
"overall survival":1,
"benign nodule":1,
"elastography":2,
"head and neck ultrasound":2,
"prospective":1,
"sonography":2,
"Doppler sonography":1,
"calcification":2,
"diffuse large B-cell lymphoma":1,
"nodular goiter":1,
"thyroid lymphoma":1,
"carotid artery pulsation":1,
"thyroid ultrasound":1,
"BRAF inhibitors":1,
"Follicular thyroid cancer":1,
"MEK inhibitors":1,
"Radioactive iodine refractory differentiated thyroid cancer":1,
"Tyrosine kinase inhibitors":2,
"esophageal squamous cell carcinoma":2,
"rare case":1,
"synchronous":1,
"thyroid carcinoma":1,
"adenocarcinoma":1,
"follicular":1,
"neoplasm metastasis":1,
"skull nodules":1,
"thyroidectomy":1,
"PET scan":1,
"cancer metastasis":1,
"radioactive iodine therapy":1,
"sarcoidosis":1,
"Autophagy-related protein light chain 3 (LC3)-II":1,
"KISS1":1,
"KISS1R":1,
"Kisspeptin":1,
"local metastasis":1,
"tumor growth":1,
"Breast cancer":1,
"cyclophosphamide":1,
"docetaxel":1,
"neoadjuvant chemotherapy":1,
"predictive factor":1,
"triple-negative":1,
"management":1,
"radiation therapy":1,
"safety":1,
"Endoscopic thyroidectomy":1,
"Lymph nodes":1,
"Fine needle aspiration biopsy":1,
"pathogenesis":1,
"therapy":2,
"Abscess":1,
"Embolic":1,
"Pregnancy":1,
"Suppurative":1,
"Thyroiditis":1,
"BRAFV600E mutation":1,
"effusion cytology":1,
"metastatic papillary thyroid carcinoma":1,
"pleural metastasis":1,
"18F-DOPA (18F-Fluorine-18-l-dihydroxyphenylalanine)":1,
"multiple endocrine neoplasia":1,
"peritoneal carcinomatosis":1,
"Cancer screening":1,
"Disease progression":1,
"Incidence":1,
"Mammography":1,
"FNAC":1,
"Pericardial effusion":1,
"Pericardial tamponade":1,
"Bax inhibitor-1":1,
"apoptosis":1,
"non-small cell lung cancer":1,
"MALDI-TOF/TOF":1,
"biomarkers":1,
"differential in-gel electrophoresis":1,
"plasma":1,
"proteomics":1,
"C-MYC":1,
"ERG":1,
"TMPRSS2-ERG":1,
"bone sialoprotein (BSP)":1,
"osteopontin (OPN)":1,
"Fine-needle aspiration":1,
"Hurthle cells":1,
"Hyperparathyroidism":1,
"Oncocytic parathyroid adenoma":1,
"Thyroid follicular neoplasm":1,
"Hypoparathyroidism":1,
"Recurrent laryngeal nerve palsy":1,
"Surgery":1,
"à venir":1,
"Anti-thyroglobulin antibody":1,
"Anticorps antithyroglobuline":1,
"Cancer thyroïdien":4,
"Thyroglobuline":1,
"Thyroïd carcinoma":1,
"Cancer thyroïdien réfractaire à l'iode":1,
"Inhibiteurs de kinase":1,
"Radioiodine refractoriness":1,
"Radioiodine refractory thyroid cancer":1,
"Résistance à l'iode":1,
"Cementoplasty":1,
"Cimentoplastie":1,
"Cryotherapy":1,
"Cryothérapie":1,
"External radiotherapy":1,
"Metastases":1,
"Métastases":1,
"Radiofrequency":1,
"Radiothérapie externe":1,
"Adverse effects":1,
"Effets secondaires":1,
"Frénateur":1,
"Levothyroxine":1,
"Suppressive":1,
"TSH":1,
"Traitement":1,
"MAPK pathway":1,
"Next Generation Sequencing":1,
"PI3K pathway":1,
"Séquençage à haut débit":1,
"TERT":1,
"Voie des MAPK":1,
"Voie des PI3K":1,
"Airway management":1,
"Anaplastic thyroid carcinoma":1,
"Tracheotomy":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年2月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
